Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 2, Pages 383
Publisher
MDPI AG
Online
2020-02-08
DOI
10.3390/cells9020383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders
- (2020) Yam Nath Paudel et al. ACS Chemical Neuroscience
- Prestimulation of Microglia Through TLR4 Pathway Promotes Interferon Beta Expression in a Rat Model of Alzheimer’s Disease
- (2019) Niloufar Yousefi et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer’s Disease and Systemic Inflammation
- (2019) Jian Zhou et al. NEUROCHEMICAL RESEARCH
- Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease
- (2019) Elena P. Moreno-Jiménez et al. NATURE MEDICINE
- Biomarkers for Alzheimer’s disease beyond amyloid and tau
- (2019) Henrik Zetterberg et al. NATURE MEDICINE
- Hesperetin Confers Neuroprotection by Regulating Nrf2/TLR4/NF-κB Signaling in an Aβ Mouse Model
- (2019) Muhammad Ikram et al. MOLECULAR NEUROBIOLOGY
- Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway
- (2019) Xin Jin et al. CNS Neuroscience & Therapeutics
- Inflammatory biomarkers in Alzheimer's disease plasma
- (2019) Angharad R. Morgan et al. Alzheimers & Dementia
- Human Hippocampal Neurogenesis Persists in Aged Adults and Alzheimer’s Disease Patients
- (2019) Matthew K. Tobin et al. Cell Stem Cell
- Lessons from Alzheimer's Disease (AD) Clinical Trials: Instead of “A-Drug”, AD-D prevention to Avert AD
- (2019) Debomoy K. Lahiri Current Alzheimer Research
- Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
- (2019) Dawling A. Dionisio-Santos et al. Journal of Neuroinflammation
- Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases
- (2019) Masahiro Nishibori et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- TREM2 Attenuates Aβ1-42-Mediated Neuroinflammation in BV-2 Cells by Downregulating TLR Signaling
- (2019) Huiping Long et al. NEUROCHEMICAL RESEARCH
- Is Alzheimer’s Disease a Neurogenesis Disorder?
- (2019) Se Hoon Choi et al. Cell Stem Cell
- The Receptor for Advanced Glycation End Products (RAGE) and DIAPH1: Implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system
- (2019) Michael MacLean et al. NEUROCHEMISTRY INTERNATIONAL
- Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
- (2019) Yam Nath Paudel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences
- (2019) Kyria M. Webster et al. EXPERIMENTAL NEUROLOGY
- MG53 attenuates lipopolysaccharide-induced neurotoxicity and neuroinflammation via inhibiting TLR4/NF-κB pathway in vitro and in vivo
- (2019) Fangxia Guan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The role of biomarkers and imaging in the clinical diagnosis of dementia
- (2018) Antony J Bayer AGE AND AGEING
- Targeting RAGE Signaling in Inflammatory Disease
- (2018) Barry I. Hudson et al. Annual Review of Medicine
- sRAGE prolonged stem cell survival and suppressed RAGE-related inflammatory cell and T lymphocyte accumulations in an Alzheimer's disease model
- (2018) Seyeon Oh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Role of the peripheral innate immune system in the development of Alzheimer's disease
- (2018) Aurélie Le Page et al. EXPERIMENTAL GERONTOLOGY
- Extracellular HMGB1 as a therapeutic target in inflammatory diseases
- (2018) Ulf Andersson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- RAGE mediates Aβ accumulation in a mouse model of Alzheimer’s disease via modulation of β- and γ-secretase activity
- (2018) Fang Fang et al. HUMAN MOLECULAR GENETICS
- TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer’s Disease and in Response to Hippocampal Deafferentation in Rodents
- (2018) Justin Miron et al. JOURNAL OF ALZHEIMERS DISEASE
- Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease–related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence
- (2018) Hamid Gholami Pourbadie et al. NEUROBIOLOGY OF AGING
- Novel targets in Alzheimer’s disease: A special focus on microglia
- (2018) Claudia Balducci et al. PHARMACOLOGICAL RESEARCH
- Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?
- (2018) Cyril Laurent et al. Biomedical Journal
- Specific alterations in the circulating levels of the SIRT1, TLR4, and IL7 proteins in patients with dementia
- (2018) Ulkan Kilic et al. EXPERIMENTAL GERONTOLOGY
- The AD-CSF-Index Discriminates Alzheimer's Disease Patients from Healthy Controls: A Validation Study
- (2018) Jose L. Molinuevo et al. JOURNAL OF ALZHEIMERS DISEASE
- In vivo molecular imaging of neuroinflammation in Alzheimer's disease
- (2018) Aisling Chaney et al. JOURNAL OF NEUROCHEMISTRY
- Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus
- (2018) Ya-jun Li et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- RAB10: an Alzheimer’s disease resilience locus and potential drug target
- (2018) Justina Tavana et al. Clinical Interventions in Aging
- HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-κB signaling in primary hippocampal neurons induced by Aβ25–35
- (2018) Ke Nan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Oral Pretreatment of Glycyrrhizin Prevents Surgery-Induced Cognitive Impairment in Aged Mice by Reducing Neuroinflammation and Alzheimer’s-Related Pathology via HMGB1 Inhibition
- (2017) Zhong-Hong Kong et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease
- (2017) Qianfeng Hu et al. Molecular Medicine Reports
- RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?
- (2017) Shi Du Yan et al. JOURNAL OF ALZHEIMERS DISEASE
- Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer’s disease mouse model
- (2017) Chiara Criscuolo et al. Scientific Reports
- Dipeptidyl Vinyl Sulfone as a Novel Chemical Tool to Inhibit HMGB1/NLRP3-Inflammasome and Inflamma-miRs in Aβ-Mediated Microglial Inflammation
- (2016) Ana S. Falcão et al. ACS Chemical Neuroscience
- Regulation of Posttranslational Modifications of HMGB1 During Immune Responses
- (2016) Yiting Tang et al. ANTIOXIDANTS & REDOX SIGNALING
- 18α-Glycyrrhetinic Acid Proteasome Activator Decelerates Aging and Alzheimer's Disease Progression in Caenorhabditis elegans and Neuronal Cultures
- (2016) Nikoletta Papaevgeniou et al. ANTIOXIDANTS & REDOX SIGNALING
- Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression
- (2016) Michelle Go et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Gx-50 reduces β-amyloid-induced TNF-α, IL-1β, NO, and PGE2expression and inhibits NF-κB signaling in a mouse model of Alzheimer's disease
- (2016) Shi Shi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease
- (2016) Xiao-Yan Xu et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Stimulation of TLR4 Attenuates Alzheimer’s Disease–Related Symptoms and Pathology in Tau-Transgenic Mice
- (2016) Yiren Qin et al. JOURNAL OF IMMUNOLOGY
- HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease
- (2016) Barry W. Festoff et al. Journal of Neuroinflammation
- A Novel, Multi-Target Natural Drug Candidate, Matrine, Improves Cognitive Deficits in Alzheimer’s Disease Transgenic Mice by Inhibiting Aβ Aggregation and Blocking the RAGE/Aβ Axis
- (2016) Lili Cui et al. MOLECULAR NEUROBIOLOGY
- In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
- (2016) Matteo Santoro et al. NEUROBIOLOGY OF DISEASE
- Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer’s disease
- (2016) Q. Zeng et al. NEUROSCIENCE
- HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease
- (2016) Kyota Fujita et al. Scientific Reports
- Hesperidin attenuates learning and memory deficits in APP/PS1 mice through activation of Akt/Nrf2 signaling and inhibition of RAGE/NF-κB signaling
- (2015) Yan Hong et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of RAGE in Alzheimer’s Disease
- (2015) Zhiyou Cai et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- The Role of Neuroinflammation in Dementias
- (2015) Giuseppe Pasqualetti et al. Current Neurology and Neuroscience Reports
- RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes
- (2015) Gurdip Daffu et al. DIABETES
- HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma
- (2015) Wei Chi et al. Journal of Neuroinflammation
- Unknown
- (2015) Huan Yang et al. MOLECULAR MEDICINE
- Immune attack: the role of inflammation in Alzheimer disease
- (2015) Frank L. Heppner et al. NATURE REVIEWS NEUROSCIENCE
- Receptor for advanced glycation end-products in neurodegenerative diseases
- (2015) Judyta Juranek et al. REVIEWS IN THE NEUROSCIENCES
- S100B Inhibitor Pentamidine Attenuates Reactive Gliosis and Reduces Neuronal Loss in a Mouse Model of Alzheimer’s Disease
- (2015) Carla Cirillo et al. Biomed Research International
- EFFICACY OF RAGE ANTAGONISTS IN MURINE MODEL OF ALZHEIMER'S DISEASE
- (2014) Matthew J. Kostura et al. Alzheimers & Dementia
- The functions of HMGB1 depend on molecular localization and post-translational modifications
- (2014) U. Andersson et al. JOURNAL OF INTERNAL MEDICINE
- Unknown
- (2014) Melinda Magna et al. MOLECULAR MEDICINE
- Clinical trial of an inhibitor of RAGE-A interactions in Alzheimer disease
- (2014) D. Galasko et al. NEUROLOGY
- Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1–RAGE interaction
- (2014) Yu Okuma et al. NEUROPHARMACOLOGY
- A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species
- (2014) Céline Vaure et al. Frontiers in Immunology
- TREM2 and the neuroimmunology of Alzheimer's disease
- (2013) Suzanne E. Hickman et al. BIOCHEMICAL PHARMACOLOGY
- p35 Deficiency Accelerates HMGB-1-mediated Neuronal Death in the Early Stages of an Alzheimer’s disease Mouse Model
- (2013) Ahram Jang et al. Current Alzheimer Research
- High-Mobility Group Box-1 Protein and -Amyloid Oligomers Promote Neuronal Differentiation of Adult Hippocampal Neural Progenitors via Receptor for Advanced Glycation End Products/Nuclear Factor- B Axis: Relevance for Alzheimer's Disease
- (2013) V. Meneghini et al. JOURNAL OF NEUROSCIENCE
- Glycyrrhizin Alleviates Neuroinflammation and Memory Deficit Induced by Systemic Lipopolysaccharide Treatment in Mice
- (2013) Jeong-Ho Song et al. MOLECULES
- An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies
- (2013) Domenica Musumeci et al. PHARMACOLOGY & THERAPEUTICS
- Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology
- (2013) J.-P. Michaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenesis and Disease-modifying Therapy in Alzheimer's Disease: The Flat Line of Progress
- (2012) Rudy J. Castellani et al. ARCHIVES OF MEDICAL RESEARCH
- The macrophage response towards LPS and its control through the p38MAPK–STAT3 axis
- (2012) Johannes G. Bode et al. CELLULAR SIGNALLING
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease
- (2012) Rashid Deane et al. JOURNAL OF CLINICAL INVESTIGATION
- HMGB1 in Development and Diseases of the Central Nervous System
- (2012) Ping Fang et al. MOLECULAR NEUROBIOLOGY
- HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
- (2012) Helena Erlandsson Harris et al. Nature Reviews Rheumatology
- Structural Biology of the Toll-Like Receptor Family
- (2011) Jin Young Kang et al. Annual Review of Biochemistry
- New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs
- (2011) Salvatore Salomone et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells
- (2011) Hiroaki Ito et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products
- (2011) Andréy Mazarati et al. EXPERIMENTAL NEUROLOGY
- Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade
- (2011) Hemachander Capiralla et al. JOURNAL OF NEUROCHEMISTRY
- TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease
- (2011) Min Song et al. Journal of Neuroinflammation
- Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease
- (2011) Wei Zhang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
- (2010) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- HMGB proteins: Interactions with DNA and chromatin
- (2010) Michal Štros Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Neuroinflammatory processes in Alzheimer’s disease
- (2010) Michael T. Heneka et al. JOURNAL OF NEURAL TRANSMISSION
- The Genetics of Alzheimer Disease: Back to the Future
- (2010) Lars Bertram et al. NEURON
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes
- (2009) Ana M. Avalos et al. AUTOIMMUNITY
- RAGE-dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer’s disease
- (2009) Fang Fang et al. FASEB JOURNAL
- HMGB1 loves company
- (2009) Marco E. Bianchi JOURNAL OF LEUKOCYTE BIOLOGY
- CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar A -Stimulated Microglial Activation
- (2009) E. G. Reed-Geaghan et al. JOURNAL OF NEUROSCIENCE
- Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
- (2009) Velandai Srikanth et al. NEUROBIOLOGY OF AGING
- Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease
- (2008) Miles C. Miller et al. BRAIN RESEARCH
- With a little help from my friends: modulation of phagocytosis through TLR activation
- (2008) Erin Tricker et al. CELL RESEARCH
- Evidence for Altered LRP/RAGE Expression in Alzheimer Lesion Pathogenesis
- (2008) Brian Jeynes et al. Current Alzheimer Research
- Association between the Polymorphisms of TLR4 and CD14 Genes and Alzheimers Disease
- (2008) C. Balistreri et al. CURRENT PHARMACEUTICAL DESIGN
- Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease
- (2008) Jing-Ji Jin et al. Journal of Neuroinflammation
- Unknown
- (2008) John Klune et al. MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started